32例成人继发性噬血细胞综合征临床特点和预后分析

doi:10.6040/j.issn.1671-7554.0.2019.983

摘要/Abstract

摘要： 目的探讨成人继发性噬血细胞综合征(HLH)临床特征和预后因素。方法收集32例成人继发性HLH患者临床资料,其中男17例(53%),女15 例(47%),19~88岁,中位年龄57岁。回顾性分析HLH患者的临床特点、病因及复发,采用单因素和Cox多因素分析预后因素。结果 32例发热和血清铁蛋白升高,26例肝脾肿大,25例血细胞减少。病因分析中恶性肿瘤相关14例(43.75%),感染相关10例(31.25%),其他8例(25%)。32例最终死亡24例(75%),中位生存期27 d,复发率11.10%。单因素方差分析示,年龄、皮疹、血红蛋白、甘油三酯、凝血时间、活化部分凝血酶原时间与死亡相关(P<0.05),Cox多因素分析显示,年龄、甘油三酯水平是预后的独立危险因素。结论成人继发性HLH病因和临床特点多样,高龄和高甘油三酯是其死亡相关的独立预后因子。

关键词: 临床特点, 噬血细胞综合征, 预后因素, 复发

Abstract: Objective To investigate the clinical features and prognostic factors of adult secondary hemophagocytic lymphohistiocytosis(HLH). Methods Clinical data of 32 cases of adult secondary HLH were collected, clinical features, etiology and recurrence were reviewed, and prognostic factors were analyzed with univariate and Cox multivariate analyses. Results Of the 32 patients, 17(53%)were male and 15(47%)were female, median age 57(19-88)years. Fever and elevated serum ferritin were observed in 32 cases, hepatosplenomegaly in 26 cases, and cytopenia in 25 cases. Etiology analyses showed that 14 cases(43.75%)were caused by malignant tumors, 10(31.25%)by infections, and 8(25%)by other factors. Ultimately 24(75%)deaths occurred. The median survival was 27 days and recurrence rate was 11.1%. One-way analysis of variance showed that age, rash, hemoglobin, triglyceride, clotting time and activated partial prothrombin time were related to death(P<0.05). Cox multivariate analysis indicated that age and triglyceride level were independent risk factors for prognosis. Conclusion Secondary HLH in adults has diverse etiology and clinical features. Advanced age and high triglyceride level are independent prognostic factors associated with death.

Key words: Clinical features, Hemophagocytic lymphohistiocytosis, Prognostic factors, Recurrence

中图分类号:

R551.3

李凡,邵建华,赵红玉,窦春慧,吕亚辉,李大启. 32例成人继发性噬血细胞综合征临床特点和预后分析[J]. 山东大学学报 (医学版), 2019, 57(12): 62-67.

LI Fan, SHAO Jianhua, ZHAO Hongyu, DOU Chunhui, LÜ Yahui, LI Daqi. Clinical features and prognosis of adult secondary hemophagocytic syndrome: an analysis of 32 cases[J]. Journal of Shandong University (Health Sciences), 2019, 57(12): 62-67.

参考文献

[1] Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis[J]. Cancer, 1979, 44(3): 993-1002.
[2] Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
[3] Marsh RA, Allen CE, McClain KL, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab[J]. Pediatr Blood Cancer, 2013, 60(1): 101-109.
[4] Wang Y, Huang W, Hu L, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis[J]. Blood, 2015, 126(19): 2186-2192.
[5] Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis[J]. Arch Dis Child, 1952, 27(136): 519-525.
[6] Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok[J]. Klin Padiatr, 2009, 221(5): 278-285.
[7] Zhang L, Zhou J, Sokol L. Hereditary and acquired hemophagocytic lymphohistiocytosis[J]. Cancer control, 2014, 21(4): 301-312.
[8] Xu XJ, Wang HS, Ju XL, et al. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study[J]. Pediatr Blood Cancer, 2017, 64(4). doi: 10.1002/pbc.26264.
[9] Zhang Z, Wang J, Ji B, et al. Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children[J]. Clinics(Sao Paulo), 2016, 71(4): 205-209.
[10] Lim SH, Park S, Jang JH, et al. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis[J]. Ann ematol, 2016, 95(2): 325-335.
[11] Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases[J]. Rheumatology(Oxford), 2008, 47(11): 1686-1691.
[12] Fei Li, Yijun Yang, Fengyan Jin, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China[J]. Orphanet J Rare Dis, 2015, 10: 20. doi: 10.1186/s13023-015-0224-y.
[13] Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide[J]. Br J Haematol, 2015, 168(1): 63-68.
[14] Aulagnon F, Lapidus N, Canet E, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis[J]. Am J Kidney Dis, 2015, 65(6): 851-859.
[15] Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis[J]. Mayo Clin Proc, 2014, 89(4): 484-492.
[16] Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases[J]. Int J Hematol, 2001, 74(2): 209-213.
[17] Rivière S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients[J]. Am J Med, 2014, 127(11): 1118-1125.
[18] 林珺芳, 曾志勇, 杨阿碰, 等. 合并噬血细胞综合征对非霍奇金淋巴瘤患者的临床预后影响及影响因素分析[J]. 中国实验血液学杂志, 2017, 25(4): 1042-1046. LIN Junfang, ZENG Zhiyong, YANG Apeng, et al. Effect of Complicated Hemophagocytic Syndrome on Clinical Prognosis of Patients with Non-Hodgkins Lymphoma and Analysis of Its Affecting Factors[J]. Journal of Experimental Hematology, 2017, 25(4): 1042-1046.
[19] Kaito K, Kobayashi M, Katayama T, et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases[J]. Eur J Haematol, 1997, 59(4): 247-253.
[20] Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients[J]. Medicine(Baltimore), 2014, 93(2): 100-105.
[21] Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis[J]. Am J Hematol, 2015, 90(3): 220-224.
[22] Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis[J]. Intensive Care Med, 2010, 36(10): 1695-1702.
[23] Tseng YT, Sheng WH, Lin BH, et al. Causes, clinical symptoms, and outcomes of infectious、diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults[J]. J Microbiol Immunol Infect, 2011, 44(3): 191-197.
[24] Okamoto M, Yamaguchi H, Isobe Y, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome[J]. Intern Med, 2009, 48(10): 775-781.
[25] Tengku-Muhammad TS, Hughes TR, Cryer A, et al. Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines[J]. Cytokine, 1996, 8(7): 525-533.
[26] Xue H, Chen C, Li W, et al. Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome[J]. Minerva Pediatr, 2015, 67(3): 251-261.
[27] Yanagisawa R, Matsuda K, Ohga S, et al. Correction to: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol[J]. Int J Hematol, 2019, 109(5): 629.

相关文章 15

[1]	张莹王宏伟王慧陈福琴. Graves病复发患者外周血中转化生长因子β1水平的变化[J]. 山东大学学报(医学版), 2209, 47(6): 80-.
[2]	万文静,高姗姗. 低分子肝素在生殖领域的应用[J]. 山东大学学报 (医学版), 2025, 63(6): 117-124.
[3]	杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[4]	石军,牛子捷,王军,马丽晶,奚春花,肖洋. 幼年型复发性呼吸道乳头状瘤病肺部播散的临床特点及麻醉要点[J]. 山东大学学报 (医学版), 2024, 62(12): 82-89.
[5]	唐小雨,王云彦,史有奎,王敏. 肉芽肿性多血管炎继发肥厚性硬脑膜炎1例[J]. 山东大学学报 (医学版), 2023, 61(5): 122-124.
[6]	李晴,张安娜,杜艳圣,刁久洲,崔若瑾,付鹏蕊,岳欣毅,周庆博. 47例单个脊髓炎性脱髓鞘病灶转化的影响因素[J]. 山东大学学报 (医学版), 2023, 61(5): 37-43.
[7]	高中霞,张铭,樊明德,谭晨阳,王梦迪,王超,樊跃飞,丁守銮,王成伟. 伽玛刀治疗81例肺癌脑转移瘤的疗效及预后因素[J]. 山东大学学报 (医学版), 2022, 60(8): 44-49.
[8]	江子晴,曾彦平,纪晓栋,左俊岭. 马尔尼菲篮状菌感染继发噬血细胞综合征1例文献报道[J]. 山东大学学报 (医学版), 2022, 60(8): 91-97.
[9]	孔昕欣,孙书珍,李倩,陈元,周爱华,王莉,姚秀俊. 抗H因子抗体阳性溶血尿毒综合征7例分析[J]. 山东大学学报 (医学版), 2022, 60(4): 82-86.
[10]	左立平,蒋丰洋,周斌彬,范金蕾,梁永锋,邓展昊,于德新. 术前MRI在预测169例肝细胞肝癌微血管侵犯及早期复发的价值[J]. 山东大学学报 (医学版), 2022, 60(3): 89-95.
[11]	孙晨曦, 王永静, 李爱, 宋宁霞, 陈慧娴, 冯晓丽, 邓玉鹏, 王涓冬, 郑成云. 1例罕见成年XLP-1病例报道[J]. 山东大学学报 (医学版), 2022, 60(3): 117-120.
[12]	马瑞杰,朱良明,左太阳,李春海,张楠,孙志钢. 微波消融治疗非小细胞肺癌根治术后肺寡转移瘤的预后分析[J]. 山东大学学报 (医学版), 2022, 60(12): 63-68.
[13]	时萧寒,李华玉,李峰. 接受Stupp方案治疗的老年胶质母细胞瘤患者预后的影响因素[J]. 山东大学学报 (医学版), 2022, 60(10): 42-48.
[14]	国云飞,舒强. 免疫抑制剂在风湿病相关复发性流产中的应用[J]. 山东大学学报 (医学版), 2021, 59(8): 38-43.
[15]	赵冰清,高选,李江夏. 基于辅助生殖人群的复发性流产夫妇染色体核型回顾性分析[J]. 山东大学学报 (医学版), 2021, 59(7): 26-31.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed